1. Home
  2. INLX vs LTRN Comparison

INLX vs LTRN Comparison

Compare INLX & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intellinetics Inc.

INLX

Intellinetics Inc.

BUY

Current Price

$4.58

Market Cap

21.6M

Sector

Technology

ML Signal

BUY

Logo Lantern Pharma Inc.

LTRN

Lantern Pharma Inc.

HOLD

Current Price

$0.67

Market Cap

10.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INLX
LTRN
Founded
1996
2013
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.6M
10.0M
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
INLX
LTRN
Price
$4.58
$0.67
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $17.50
AVG Volume (30 Days)
24.2K
★ 305.2K
Earning Date
11-05-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 18.65
EPS
★ N/A
N/A
Revenue
★ $11,336.00
N/A
Revenue This Year
$14.57
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$4.12
$0.60
52 Week High
$10.33
$4.34

Technical Indicators

Market Signals
Indicator
INLX
LTRN
Relative Strength Index (RSI) 43.11 21.64
Support Level N/A N/A
Resistance Level $6.00 $1.96
Average True Range (ATR) 0.93 0.09
MACD -0.01 0.03
Stochastic Oscillator 17.00 17.25

Price Performance

Historical Comparison
INLX
LTRN

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Software and Document Services. The Software segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Services offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Services Segment.

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

Share on Social Networks: